Volume 5, Issue 3 (8-2020)                   J Res Dent Maxillofac Sci 2020, 5(3): 1-6 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirzaiy M, Neshat F. Effect of Areca Nut on Oral Health: A Review. J Res Dent Maxillofac Sci 2020; 5 (3) :1-6
URL: http://jrdms.dentaliau.ac.ir/article-1-276-en.html
1- Associated professor, Oral and Dental Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. , shirzaiy@gmail.com
2- Assistant professor, Oral and Dental Disease Research Center, Zahedan University of Medical Sciences
Keywords: Areca, Habits, Oral Health
Full-Text [PDF 309 kb]   (1763 Downloads)     |   Abstract (HTML)  (4314 Views)
Full-Text:   (1817 Views)


Abstract


Background and Aim: Oral health can be influenced by habitual areca nut chewing. The consumption of products containing areca nut, such as paan, gutkha, supari, etc., is common in Asian countries, such as India, Bangladesh, and Pakistan. In Iran, areca nut product consumption is common in the southeast of Iran, especially in Chabahar, Iranshahr, and Nikshahr cities, which are in proximity to the Pakistan border. These products are easily accessible in these areas and are widely used due to a lack of awareness about their disadvantages. Areca nut contains tannins and alkaloids, such as arecaidine, guvacine, arecoline, and guvacoline. Arecaidine can stimulate the synthesis of collagen by stimulation and proliferation of fibroblasts. This review article aims to evaluate the effects of areca nut on oral health.
Materials and Methods: Research was performed in the PubMed, ScienceDirect, Web of Science, Google Scholar, and Scopus databases, and 35 articles were selected in total.
Results: By reviewing the studies, it was found that areca nut products cause periodontal disease as well as oral lesions, which can become malignant with continuing use.
Conclusion: Areca nut product chewing has deleterious effects on oral and dental health. Tooth fracture, periodontal disease, leukoplakia, lichenoid lesions, oral submucous fibrosis (OSF), and oral cancer can be correlated with areca nut use. Therefore, public health proceeding to discontinue areca nut consumption is advised to control premalignant and malignant lesions, such as OSF and oral cancer.
Keywords: Areca, Habits, Oral Health

 
Introduction


Areca nut use is a habit of a great ancient history. This habit is universally accepted among some sections of the society, including children and females. The reasons for the popularity of areca nut chewing are as follows: addiction, social acceptance, religious beliefs, and understood health benefits. (1,2)
Different products, like khaini, pan masala, mawa, paan, and gutkha, contain areca nut.
Areca nut (or betel) is the fourth most prevalent used psychotropic substance across the world after caffeine, alcohol, and nicotine. Some reasons for areca nut chewing are pain relief, euphoria, refreshment, increasing saliva, etc. (1,3)
Habitual areca nut chewing can be deleterious to human health. The World Health Organization (WHO) knows areca nut, as a psychoactive substance, as group 1 human carcinogens. (4,5)
Habitual areca nut chewing is very common in Southeast Asia but due to its widespread use, it has spread to North America and Europe. The mortality rate of habitual areca nut chewing is significant because it can cause oral squamous cell carcinoma (OSCC; 2.3%-7.6%). (1,6)
Areca nut is an endosperm of the fruit of the catechu tree (Figure 1). It is composed of tannins, which among them, de catechol and lottanic acids are the most important. Areca nut is composed of alkaloids, including arecoline (the most abundant), arecolidine, guvacine, guvacoline, and arecaidine, which their amount in areca nut is low. The most predominant polyphenols in areca nut include hexahydroxiflavans, flavonoids, 4-Diols, flavan-3, leucocyanidines, tannins, and catechin. Other polyphenols, like gallotannic, gallic acid, epicatechin, phlobatannin, D-catechol, and epicatechin are minor polyphenols of areca nut. Due to the increasing gutkha (composed of areca nut, tobacco, and betel quid) and pan masala consumption, the age of oral submucous fibrosis (OSF) development has decreased. Areca nut contains trace elements, such as vanadium, copper, manganese, chlorine, and bromide; therefore, areca nut consumers are exposed to abundant concentrations of potentially cancerous constitutes. Areca use results in continuous irritation of oral mucosal tissues by different materials, such as copper, tannins, catechins, and alkaloids. (6,7)
Around 600 million individuals use areca nut products around the world. Betel quid (one of the products containing areca nut) is the most predominantly used substance after nicotine, ethanol, and caffeine. (1,8)
The habit of betel use is common in South Africa and South Asia and is also becoming prevalent in American and European countries. Betel consists of areca nut, lime (calcium hydroxide), and fresh leaves of piper betel species. Different areca nut products (paan, mawa, and gutkha) are predominantly used in South Asia. Mawa is composed of areca nut, tobacco, and lime. The rate of prevalence of use in India varies between 0.2% and 10.9%. (1,3,9-11)
Areca nut and its derivatives have deleterious effects on the oral mucosa. These products affect periodontal and dental tissues. In areca-retained sites, especially in chronic betel nut chewers, lichenoid lesions and leukoplakia develop. OSF as a lesion with the highest premalignant potential and oral cancer result from long-term areca nut chewing combined with tobacco. (1,4,12)
Parmar et al assessed the effect of using a mixture of areca nut and tobacco on oral hygiene status and periodontal tissues. (13) They found that quid chewers remarkably suffered from gingival bleeding, limitation in mouth opening, difficulty in swallowing solid food, and halitosis. Oral ulcers and burning sensation in the oral mucosa as well as gingival recession, gingival lesions, and periodontal pockets were more prevalent in areca chewers. (13)
Areca or betel chewing has adverse effects on oral hygiene as well as the incidence of oral lesions and periodontal diseases. (13)
There are limited studies on the use of areca nut-derived products and OSF prevalence in Iran. Only two related studies have been performed in Southeast Iran. The consumption of paan, supari, and gutkha is common in Southeast Iran (Figure 2). (14,15) The results of these studies indicate that the use of areca nut-derived products is common in Southeast Iran, and OSF is prevalent in this region. The age of areca usage is low, and primary schoolchildren use these products. In addition, females use some areca products such as supari for cosmetic goals. People are not aware of the harms of areca nut usage. A lack of awareness about the harms of consumption and the easy availability of these products are the main causes of the high usage of these products in Southeast Iran. Some people even believe that areca nut products are beneficial to health.
There is no study about the effects of areca nut usage on dental health, and only the effect of areca nut on the oral mucosa has been studied. In a few performed studies in Iran, OSF has been found to be the most frequent oral lesion related to areca nut usage.
Areca nut products have harmful effects on human health, particularly oral and dental health. The reviewing of data about areca nut product use and its effect on oral and dental health in this review article can be useful for dental clinicians in the early diagnosis, proper management, and reduction of morbidity and mortality of the diseases related to areca nut.
Dental workers can describe for users the harmful effects of areca on human health. They can especially advise parents to prevent areca nut use by children.

Figure 1. Areca nut fruit and its preparation  
Figure 2. Paan and supari


Materials and Methods


This study is a simple overview (2020) by searching the Google Scholar, PubMed, Scopus, ScienceDirect, and Web of Science databases (about 36 articles) with the following keywords: areca nut, habits, and oral health, from 1990 to 2020.
Resources in which the effects of areca nut-derived products on oral and dental health were reported were used whereas old studies or studies that had only reported the epidemiology of the related diseases without describing the effects of areca nut usage were excluded from the study.


Results


By reviewing the studies, it was found that areca nut products cause periodontal disease as well as oral lesions, which can become malignant with ongoing use.


Discussion


Areca nut use can be harmful to oral and dental health. Some harmful effects of areca nut chewing on dental health are as follows:
Tooth abrasion and fractured teeth:
Areca nut chewing can lead to occlusal abrasion and tooth fracture due to its hard fibrous nature. Shortening of the incisors is one of the complications of betel or areca nut chewing. In areca nut chewers, occlusal surfaces of the premolars and molars become smooth. Enamel abrasion and dentinal sensitivity often occur. (16,17)
Areca nut staining:
Copious red saliva is produced following areca nut chewing. In addition, polymers of ortho quinones discolor the teeth. Tooth discoloration depends on the duration of areca nut use and differs from red to black (Figure 3). (1,16) 
 
Figure 3. Dental staining in an areca nut user
 
Tooth decay:
Regular areca nut chewing diminishes tooth decay due to the following reasons:
1-Production of sclerotic dentin following dental attrition.
2-Areca nut stain coats dental surfaces and it may protect against demineralization of the teeth.
3-Antimicrobial properties of tannin of areca nut.
4- Increased salivary pH following areca nut chewing.   
Some epidemiological studies have indicated that the rate of dental caries in areca nut chewers is lower than that in non-chewers. (18) Other studies have reported no differences in dental caries between areca nut consumers and non-consumers. (19)
The impact of areca nut usage on the oral mucosa:
Whitish gray discoloration of the oral mucosa occurs in some areca nut chewers. Others may have healthy mucosa without discoloration or textural change. (1,20)
Lichenoid lesions and oral leukoplakia following areca nut use:
There are reports about lichenoid oral lesion development following areca nut use. These lesions often occur at the site of placement of areca nut products. With habit cessation, this lesion may regress completely. (21)   
Oral leukoplakia generally occurs as a white plaque or patch on the oral mucosa and is not characterized pathologically or clinically as any other oral lesion. It may be related to tobacco use in some cases. It has been reported that areca nut product consumption is a major risk factor for oral leukoplakia development. (22)    
SCC:
It has been indicated that long-term areca nut chewing can lead to OSCC development (Figure 4). Areca nut and its derivatives have been known as human carcinogen type 1. Products containing areca nut and tobacco increase the relative risk of OSCC development. (1,23) Areca nut and betel quid are strong and independent risk factors for oral cancer. (24)

Figure 4. Transformation of oral leukoplakia to oral squamous cell carcinoma (OSCC) in an areca nut user

OSF:
OSF is a precancerous condition with the highest malignant potential among oral mucosal lesions. The most common factor for OSF development is areca nut use. (6,25)
Areca nut causes overproduction of collagen by fibroblast stimulation. Overproduction of collagen and its deposition in the soft tissue of the oral mucosa decrease the flexibility of the oral mucosa. (1,6)
OSF manifests as a severe reduction in mouth opening and rigidity and blanching of oral soft tissues (Figure 5). Most people afflicted by OSF attend to dental clinics due to the reduction of mouth opening and rigidity of the oral mucosa, leading to difficulty in speech, chewing, and swallowing. (14,16)
OSF is more common in men in the third decade of life. It commonly occurs in the buccal mucosa and the palate. (6,26)
This condition is irreversible, and there is no effective treatment for this premalignant lesion. If OSF is left untreated, the lesion would transform to OSCC. Therefore, preventing OSF is very important. Many studies show that areca nut use has a strong correlation with OSF. Based on the findings of these studies, the most important factor contributing to OSF development is areca nut product use. Factors such as the frequency, amount, and duration of areca nut consumption are correlated with OSF development. (6,15,25-29)
OSF has the highest malignant transformation potential among oral precancerous lesions. Although epidemiological studies have revealed that the essential factor for OSF development is areca nut consumption, other factors such as tobacco, lime, and chilies consumption, as well as immunological disorders, genetics, nutritional deficiencies (iron and zinc), and collagen disorders contribute to OSF development. (1,6,8,25)
Several treatment modalities have been presented for relieving the symptoms of OSF but none of them leads to complete resolution of the disease. (6)
 
Figure 5. Limitation in mouth opening and blanching and rigidity of the oral mucosa in an oral submucous fibrosis (OSF) patient

OSF treatment modalities:
Habit cessation: The first and most important step of treatment is the cessation of the habit of areca nut chewing. Education regarding habit cessation and ending the use of areca nut products and irritants such as spicy and hot food, smoking, and alcohol consumption are important for the promotion of oral health in areca nut users. (6,29,30)
Steroid therapy: Steroids act by the reduction of fibroblast proliferation, which decreases the number of collagen fibers. The release of cellular protease enzymes in the extracellular compartment by steroids in the connective tissues causes collagen and zymogen activation, leading to the ingestion of insoluble collagen and stimulation of collagen breakdown.
Intralesional injection of dexamethasone as well as the use of steroid ointments are usually advised. (6,31,32)
Immune milk: One of the anti-inflammatory components used in recent years to relieve symptoms in patients with OSF is the immune milk, which relieves the symptoms in OSF patients with stimulation of cytokine production and suppression of inflammatory processes. (33)
Turmeric powder: Turmeric powder, as an excellent scavenger of free radicals, is used for OSF treatment. The mechanism of the effect of turmeric powder is through the production of micronuclei in circulating lymphocytes influenced by Benzo(a)pyrene in turmeric powder. Turmeric resin and turmeric oil synergistically protect cells against DNA damage. (6)
Interferon-gamma (IFN-α): INF-α is an antifibrotic cytokine, which regulates the immune system. Intralesional injection of INF-α for patients with OSF relieves the symptoms. (6,34)
Physiotherapy and Surgery: One method of prevention of mouth opening reduction is muscle stretching exercises thorough physiotherapy. OSF patients with severe trismus can be cured with surgical intervention under general anesthesia, which consists of excision of fibrotic bands and reconstruction along with myotomy of the temporalis muscle as well as coronoidectomy. (6,35) However, surgical intervention and pharmacotherapy do not eliminate the disease, especially if the habit of areca usage is continued.
In a systematic review, by evaluation of 28 articles about areca nut hazards, the authors explained that areca nut chewing is associated with cardiovascular disorders, cerebrovascular disorders, obesity, hyperglycemia, metabolic syndrome, type 2 diabetes mellitus, hepatic disorders, esophageal inflammation and fibrosis, respiratory discomfort, and renal disorders. (35) Areca nut chewing adversely affects systemic health by damaging vital organs. Therefore, general human health as well as oral health are influenced by areca nut use. (36)
Conclusion


Based on the collected contents from reliable sources on the harmful effects of areca nut on oral and dental health, it can be concluded that betel quid and areca nut usage in any form is unsafe for oral and dental health. Considering the reviewed literature, dental hard tissues and oral soft tissues are influenced by areca nut use. Areca nut and its derivatives have deleterious effects on the oral mucosa. These products have harmful effects on periodontal tissues and dental health. In areca-retained sites, especially in chronic betel nut chewers, lichenoid lesions and leukoplakia arise. OSF and oral cancer result from long-term areca nut chewing combined with tobacco; therefore, it is necessary to control the areca nut habit epidemic in different societies. For limitation of the prevalence of areca nut use, health care professionals must increase awareness of users regarding the harmful effects of areca usage as well as the signs and symptoms of OSF and OSCC. The consumers should be taught about the health risks of areca nut consumption through educational programs. Quick identification of oral lesions and timely and effective care are essential to decrease the mortality rate.

 

 

Type of Study: Review article | Subject: Oral medicine

References
1. Anand R, Dhingra C, Prasad S, Menon I. Betel nut chewing and its deleterious effects on oral cavity. J Cancer Res Ther. 2014 Jul-Sep;10(3):499-505.
2. Auluck A, Hislop G, Poh C, Zhang L, Rosin MP. Areca nut and betel quid chewing among South Asian immigrants to Western countries and its implications for oral cancer screening. Rural Remote Health. 2009 Apr-Jun;9(2):1118.
3. Aziz SR. Coming to America: betel nut and oral submucous fibrosis. J Am Dent Assoc. 2010 Apr;141(4):423-8.
4. Pankaj C. Areca nut or Betel Nut Control is Mandatory if India wants to reduce the burden of Cancer especially Cancer of the Oral Cavity. Int J Head Neck Surg. 2010;1:17-20. [DOI:10.5005/jp-journals-10001-1003]
5. Verma S. Areca nut (betel nut) chewing: a popular Indian cultural practice and its mucosal implications. Int J Dermatol. 2011 Feb;50(2):229-32. [DOI:10.1111/j.1365-4632.2010.04710.x] [PMID]
6. Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y. Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies. Natl J Maxillofac Surg. 2017 Jul-Dec;8(2):89-94. [DOI:10.4103/njms.NJMS_32_17] [PMID] [PMCID]
7. Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res. 2006 Oct-Dec;17(4):190-8. [DOI:10.4103/0970-9290.29865] [PMID]
8. Dos M, Manjunath C, Srivastava A, Malavika J, Ameena MVM. Epidemiology of Oral Submucous Fibrosis: A Review. Int J Oral Health Med Res. 2017;3(6):126-9.
9. Niaz K, Maqbool F, Khan F, Bahadar H, Ismail Hassan F, Abdollahi M. Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol Health. 2017 Mar 9;39:e2017009. [DOI:10.4178/epih.e2017009] [PMID] [PMCID]
10. Hebbar PB, Sheshaprasad R, Gurudath S, Pai A, Sujatha D. Oral submucous fibrosis in India: Are we progressing?? Indian J Cancer. 2014 Jul-Sept;51(3):222-6. [DOI:10.4103/0019-509X.146724] [PMID]
11. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous fibrosis in India: a new epidemic? Natl Med J India. 1998 May-Jun;11(3):113-6.
12. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines. Lyon (FR): International Agency for Research on Cancer; 2004. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 85.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK316567/
13. Parmar G, Sangwan P, Vashi P, Kulkarni P, Kumar S. Effect of chewing a mixture of areca nut and tobacco on periodontal tissues and oral hygiene status. J Oral Sci. 2008 Mar;50(1):57-62. [DOI:10.2334/josnusd.50.57] [PMID]
14. Shirzaii M, Momeni Z. Evaluation of oral submucosal fibrosis and related factors in areca nut users. Zahedan J Res Med Sci (ZJRMS). 2013;15(1):38-42.
15. Shirzaii M, Sarani M. Supari Consumption is a Common Oral Habit Among Women in Chabahar City. Int J High Risk Behav Addict. 2012;1(1):44-5. [DOI:10.5812/ijhrba.4177]
16. World Health Organization. Regional Office for the Western Pacific‎. Review of areca (‎betel)‎ nut and tobacco use in the Pacific : a technical report. [Internet]. 2012 [cited 5 Jul 2020]. Available from: https://apps.who.int/iris/handle/10665/206910
17. Yeh CJ. Fatigue root fracture: a spontaneous root fracture in non-endodontically treated teeth. Br Dent J. 1997 Apr 12;182(7):261-6. [DOI:10.1038/sj.bdj.4809363] [PMID]
18. Nigam P, Srivastava AB. Betel chewing and dental decay. Fed Oper Dent. 1990 Aug;1(1):36-8.
19. Williams SA, Summers RM, Ahmed IH, Prendergast MJ. Caries experience, tooth loss and oral health related behaviours among Bangladeshi women resident in West Yorkshire, UK. Community Dent Health. 1996;13(3):150 6.
20. Li YC, Cheng AJ, Lee LY, Huang YC, Chang JT. Multifaceted Mechanisms of Areca Nuts in Oral Carcinogenesis: the Molecular Pathology from Precancerous Condition to Malignant Transformation. J Cancer. 2019 Jul 8;10(17):4054-62. [DOI:10.7150/jca.29765] [PMID] [PMCID]
21. Reichart PA, Warnakulasuriya S. Oral lichenoid contact lesions induced by areca nut and betel quid chewing: a mini review. J Investig Clin Dent. 2012 Aug;3(3):163-6. [DOI:10.1111/j.2041-1626.2012.00130.x] [PMID]
22. Thomas SJ, Harris R, Ness AR, Taulo J, Maclennan R, Howes N, et al. Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. 2008 Oct 15;123(8):1871-6. [DOI:10.1002/ijc.23739] [PMID]
23. Chen PH, Mahmood Q, Mariottini GL, Chiang TA, Lee KW. Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers. Biomed Res Int. 2017;2017:3904098. [DOI:10.1155/2017/3904098] [PMID] [PMCID]
24. Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014 Nov 20;9(11):e113385. [DOI:10.1371/journal.pone.0113385] [PMID] [PMCID]
25. Prabhu RV, Prabhu V, Chatra L, Shenai P, Suvarna N, Dandekeri S. Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent. 2014 Dec ;6(5):e569-75. [DOI:10.4317/jced.51318] [PMID] [PMCID]
26. Guha N, Warnakulasuriya S, Vlaanderen J, Straif K. Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer. 2014 Sep 15;135(6):1433-43. [DOI:10.1002/ijc.28643] [PMID]
27. Ahmad MS, Ali SA, Ali AS, Chaubey KK. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India. J Indian Soc Pedod Prev Dent. 2006 Jun;24(2):84-9. [DOI:10.4103/0970-4388.26022] [PMID]
28. Shirzaii M. Oral Submucous Fibrosis in a 15-year-old Boy: The First Case Report in Iran. Shiraz Univ Dent J. 2011;11:51-5.
29. Hussain A, Zaheer S, Shafique K. School-based behavioral intervention to reduce the habit of smokeless tobacco and betel quid use in high-risk youth in Karachi: A randomized controlled trial. PLoS One. 2018 Nov 2;13(11):e0206919. [DOI:10.1371/journal.pone.0206919] [PMID] [PMCID]
30. Nagpal R, Nagpal N, Mehendiratta M, Marya CM, Rekhi A. Usage of betel quid, areca nut, tobacco, alcohol and level of awareness towards their adverse effects on health in a north Indian rural population. Oral Health Dent Manag. 2014 Mar;13(1):81-6.
31. Guo J, Xie H, Mao SH, Liang M, Wu H. Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta‐analysis of randomized controlled clinical trials. J Otolaryngol Head Neck Surg. 2020;49(4):311-19. [DOI:10.1111/jop.13009] [PMID]
32. Rao NR, Villa A, More CB, Jayasinghe RD, Ross Kerr A, Johnson NW. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg. 2020 Jan;49(3):1-11. [DOI:10.1186/s40463-020-0399-7] [PMID] [PMCID]
33. Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med. 2001 Nov;30(10):618-25. [DOI:10.1034/j.1600-0714.2001.301007.x] [PMID]
34. Azizi A, Dabirmoghadam P, Keykha F. Comparison of the Concentration of Salivary IL-8 in Patients with Oral Squamous Cell Carcinoma and Healthy Subjects . J Res Dentomaxillofac Sci. 2016; 1 (3) :28-32. [DOI:10.18869/acadpub.jrdms.1.3.28]
35. Ravikumar KK, Khan UN; Priyadarshini, Ramakrishnan K, Nachiappan S. Recurrent oral submucous fibrosis with nil mouth opening surgical management and reconstruction with bilateral nasolabial flap: A case report and review of literature. Indian J Dent Res. 2019 May-Jun;30(3):472-7. [DOI:10.4103/ijdr.IJDR_423_17] [PMID]
36. Javed F, Chotai M, Mehmood A, Almas K. Oral mucosal disorders associated with habitual gutka usage: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jun;109(6):857-64. [DOI:10.1016/j.tripleo.2009.12.038] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Research in Dental and Maxillofacial Sciences

Designed & Developed by: Yektaweb